Impact of anemia on in-hospital, one-month and one-year mortality in patients with acute coronary syndrome from the Middle East

Clinical Medicine and Research

Volumn 10, Issue 2, 2012, Pages 65-71

  Sulaiman, Kadhim ^a   Prashanth, Panduranga ^a   Al Zakwani, Ibrahim ^b   Al Mahmeed, Wael ^c   Al Motarreb, Ahmed ^d   Al Suwaidi, Jassim ^e   Amin, Haitham ^f   Asaad, Nidal ^e   Hersi, Ahmad ^g   Al Faleh, Hussam A ^g   Al Saif, Shukri A ^h   Alsheikh Ali, Alawi A ⁱ   Al Lawati, Jawad ^j   Al Habib, Khalid ^g  

^a ROYAL HOSPITAL   (Oman)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c SHEIKH KHALIFA MEDICAL CITY   (United Arab Emirates)

^d Sana's University   (Yemen)

^e HAMAD MEDICAL CORPORATION   (Qatar)

^f BAHRAIN DEFENCE FORCE HOSPITAL   (Bahrain)

^g KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^h Saud Al Babtain Cardiac Centre ^*  (Saudi Arabia)

ⁱ TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j MINISTRY OF HEALTH   (Oman)

more..

Author keywords

Acute coronary syndrome; Anemia; Hemoglobin; Middle East; Mortality

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS RISK SCORE; HEART FAILURE; HEART RATE; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; MORTALITY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE;

ACUTE CORONARY SYNDROME; AGED; ANEMIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEMOGLOBINS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; MYOCARDIAL INFARCTION; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SHOCK, CARDIOGENIC; STROKE;

EID: 84861505734     PISSN: 15394182     EISSN: 15546179     Source Type: Journal    
DOI: 10.3121/cmr.2011.1032     Document Type: Article

References (26)

1. Lipsic E, van der Horst IC, Voors AA, van der Meer P, Nijsten MW, van Gilst WH, van Veldhuisen DJ, Zijlstra F. Haemoglobin levels and 30-day mortality in patients after myocardial infarction. Int J Cardiol 2005;100:289-292.
2. Bindra K, Berry C, Rogers J, Stewart N, Watts M, Christie J, Cobbe SM, Eteiba H. Abnormal haemoglobin levels in acute coronary syndromes. QJM 2006;99:851-862.
3. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E. Association of haemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111:2042-2049.
4. Archbold RA, Balami D, Al-Hajiri A, Suliman A, Liew R, Cooper J, Ranjadayalan K, Knight CJ, Deaner A, Timmis AD. Haemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients. Am Heart J 2006;152: 1091-1095.
5. Valeur N, Nielsen OW, McMurray JJ, Torp-Pedersen C, Kober L; TRACE Study Group. Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. Eur J Heart Fail 2006;8:577-584.
6. Shu DH, Ransom TP, O'Connell CM, Cox JL, Kaiser SM, Gee SA, Rowe RC, Ur E, Imran SA. Anaemia is an independent risk for mortality after acute myocardial infarction in patients with and without diabetes. Cardiovasc Diabetol 2006;5:8.
7. Aronson D, Suleiman M, Agmon Y, Suleiman A, Blich M, Kapeliovich M, Beyar R, Markiewicz W, Hammerman H. Changes in haemoglobin levels during hospital course and long-term outcome after acute myocardial infarction. Eur Heart J 2007;28:1289-1296.
8. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Cohen DA, Negoita M, Lansky AJ, Stone GW. Impact of anaemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 2004; 44:547-553.
9. Anker SD, Voors A, Okonko D, Clark AL, James MK, von Haehling S, Kjekshus J, Ponikowski P, Dickstein K; OPTIMAAL Investigators. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J 2009;30:1331-1339.
10. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-1562.
11. Bassand JP, Afzal R, Eikelboom J, Wallentin L, Peters R, Budaj A, Fox KA, Joyner CD, Chrolavicius S, Granger CB, Mehta S, Yusuf S; OASIS 5 and OASIS 6 Investigators. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J 2010;31:50-58.
12. Alhamdan NA, Almazrou YY, Alswaidi FM, Choudhry AJ. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med 2007;9:372-377.
13. Zubaid M, Rashed WA, Al-Khaja N, Almahmeed W, Al-Lawati J, Sulaiman K, Al-Motarreb A, Amin H, Al-Suwaidi J, Al-Habib K. Clinical presentation and outcomes of acute coronary syndromes in the Gulf Registry of Acute Coronary Events (Gulf RACE). Saudi Med J 2008;29:251-255.
14. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, Flaherty JT, Harrington RA, Krumholz HM, Simoons ML, Van De Werf FJ, Weintraub WS, Mitchell KR, Morrisson SL, Brindis RG, Anderson HV, Cannom DS, Chitwood WR, Cigarroa JE, Collins-Nakai RL, Ellis SG, Gibbons RJ, Grover FL, Heidenreich PA, Khandheria BK, Knoebel SB, Krumholz HL, Malenka DJ, Mark DB, Mckay CR, Passamani ER, Radford MJ, Riner RN, Schwartz JB, Shaw RE, Shemin RJ, Van Fossen DB, Verrier ED, Watkins MW, Phoubandith DR, Furnelli T. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am CollCardiol 2001;38:2114-2130.
15. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA; Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003;163:2345-2353.
16. World Health Organization. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. Geneva, Switzerland: World Health Organization; 2001. Available at: http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/WHO_NHD_01.3/en/index.html. Accessed February 20, 2011.
17. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928-935.
18. Meneveau N, Schiele F, Seronde MF, Descotes-Genon V, Oettinger J, Chopard R, Ecarnot F, Bassand JP; Reseau de Cardiologie de Franche Comte. Anaemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol 2009;103:442-447.
19. Rousseau M, Yan RT, Tan M, Lefkowitz CJ, Casanova A, Fitchett D, Jolly SS, Langer A, Goodman SG, Yan AT; Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial Investigators. Relation between haemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring. Am J Cardiol 2010;106:1417-1422.
20. Tanne D, Molshatzki N, Merzeliak O, Tsabari R, Toashi M, Schwammenthal Y. Anaemia status, haemoglobin concentration and outcome after acute stroke: a cohort study. BMC Neurol 2010;10:22.
21. Bassand JP. Impact of anaemia, bleeding, and transfusions in acute coronary syndromes: a shift in the paradigm. Eur Heart J 2007;28:1273-1274.
22. Nakamura R, Takahashi A, Yamada T, Miyai N, Irie H, Kinoshita N, Sawada T, Azuma A, Matsubara H. Erythropoietin in patients with acute coronary syndrome and its cardioprotective action after percutaneous coronary intervention. Circ J 2009;73:1920-1926.
23. Vis MM, Sjauw KD, van der Schaaf RJ, Koch KT, Baan J Jr, Tijssen JG, Piek JJ, de Winter RJ, Henriques JP. Prognostic value of admission haemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock. Am J Cardiol 2007;99:1201-1202.
24. Tsujita K, Nikolsky E, Lansky AJ, Dangas G, Fahy M, Brodie BR, Dudek D, Möckel M, Ochala A, Mehran R, Stone GW. Impact of anaemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol 2010;105:1385-1394.
25. Kurek T, Lenarczyk R, Kowalczyk J, Swiatkowski A, Kowalski O, Stabryła-Deska J, Honisz G, Lekston A, Kalarus Z, Kukulski T. Effect of anaemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2010;105:611-618.
26. Cavusoglu E, Chopra V, Gupta A, Clark LT, Eng C, Marmur JD. Usefulness of anaemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol 2006;98:580-584.